Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115430) titled 'Efficacy and Safety of Remimazolam versus Dexmedetomidine for Sedation During Autologous Arteriovenous Fistula Creation Under Brachial Plexus Block in Patients with Uraemia: A Prospective Randomised Controlled Trial' on Dec. 25, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Condition:
uremia
Intervention:
Dexmedetomidine group:Dexmedetomidine-Assisted Sedation
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Dexmedetomidine group:81;Remimazolam gro...